NEW YORK (360Dx) – Diaceutics this week announced a collaboration with Lenovo and Intel to leverage artificial intelligence to determine if patients can be grouped based on diagnostic test information.
By doing so, the partners believe the data can help identify ways of improving diagnosis, treatment, and outcomes for patients sharing similar characteristics.